Insurer Anthem profit beats estimates on lower patient costs

(Reuters) - Anthem Inc reported a better-than-expected profit on Wednesday, driven by higher premiums and lower patient medical costs even as fewer people enrolled in its insurance plans. Enrolment fell about 2.2 percent to 39.5 million members at the end of the quarter, hit by a decline in the number of people signing up for Medicaid as well as for its Obamacare plans.

Reuters July 26, 2018 00:09:26 IST
Insurer Anthem profit beats estimates on lower patient costs

Insurer Anthem profit beats estimates on lower patient costs

(Reuters) - Anthem Inc reported a better-than-expected profit on Wednesday, driven by higher premiums and lower patient medical costs even as fewer people enrolled in its insurance plans.

Enrolment fell about 2.2 percent to 39.5 million members at the end of the quarter, hit by a decline in the number of people signing up for Medicaid as well as for its Obamacare plans.

Shares of the company rose about 1 percent to $248.24 in late morning trade.

Jefferies analyst David Windley said a combination of membership declines in the commercial business and lower guidance for members probably weighed on the stock.

The company has reduced its footprint in Obamacare markets, but Cantor Fitzgerald analysts said the decline in Obamcare membership in the quarter was seasonally normal and the reduction probably helped it to lower patient costs.

Anthem Chief Executive Officer Gail Boudreaux said the health insurer was not looking to "rescale" the Obamcare business, but was pleased with the performance this year.

"As we go into 2019, while no decisions are final yet, we are assessing that. I think you'll see some county expansions," Boudreaux said on a conference call with analysts.

The company's tight control over patient costs in the quarter improved its benefit expense ratio to 83.4 percent from 86.1 percent in the year-ago period. The figure is widely watched in the sector because it measures an insurer's expenses on claims against the premiums it earns.

Last week, larger rival UnitedHealth Group reported a benefit expense ratio that missed analysts' estimates, overshadowing better-than-expected earnings.

In contrast to the debates around UnitedHealth and Centene Corp earnings, Anthem's results is a cleaner benefit expense ratio-driven beat and raise that still includes conservatism for the second half of the year, Evercore ISI analyst Michael Newshel said in a note.

Net income rose 23 percent to $1.05 billion, or $3.98 per share, in the second quarter ended June 30.

Excluding items, the company earned $4.25 per share, ahead of analysts' average estimate of $4.16, according to Thomson Reuters I/B/E/S.

Total revenue rose 2.4 percent to $22.94 billion. Operating revenue was $22.71 billion, compared with the analysts' estimate of $22.69 billion.

The company also raised its profit forecast and now expects 2018 adjusted earnings to be greater than $15.40 per share, up from its previous estimate of earnings of greater than $15.30 per share.

(Reporting by Ankur Banerjee and Tamara Mathias in Bengaluru; Editing by Bernard Orr)

This story has not been edited by Firstpost staff and is generated by auto-feed.

Updated Date:

TAGS:

Find latest and upcoming tech gadgets online on Tech2 Gadgets. Get technology news, gadgets reviews & ratings. Popular gadgets including laptop, tablet and mobile specifications, features, prices, comparison.

also read

Putin says he has noted Joe Biden's harsh anti-Russian rhetoric
World

Putin says he has noted Joe Biden's harsh anti-Russian rhetoric

MOSCOW (Reuters) - Russian President Vladimir Putin said on Wednesday he had noted what he called "sharp anti-Russian rhetoric" from U.S. Democratic presidential candidate Joe Biden, but that he had been encouraged by Biden's comments on arms control. Putin, in comments on state television ahead of the U.S.

In hardening stance, France, Germany push for EU sanctions on Russians over Navalny
World

In hardening stance, France, Germany push for EU sanctions on Russians over Navalny

By John Irish and Robin Emmott PARIS/BRUSSELS (Reuters) - France and Germany said on Wednesday they would propose European Union sanctions against Russian individuals after receiving no credible answers from Moscow over the poisoning of Kremlin critic Alexei Navalny with a nerve agent. Several Western governments have said Russia, which has denied accusations by Navalny that it was involved in the poisoning, must help in investigations or face consequences. The decision and speed with which Europe's two main powers agreed to push ahead with sanctions suggests a hardening of the bloc's diplomacy towards Moscow.

Coronavirus patient Trump seeks ways to mount campaign comeback
World

Coronavirus patient Trump seeks ways to mount campaign comeback

By Steve Holland WASHINGTON (Reuters) - U.S. President Donald Trump, under coronavirus quarantine in the White House and restricted from traveling, is seeking ways to put a spark back in his struggling re-election bid and get behind his desk in the Oval Office with four weeks left until Election Day.